Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01884064 · ClinicalTrials.gov registry record · Phase 1
Repetitive Transcranial Magnetic Stimulation for the Treatment of Focal Hand Dystonia
A Phase 1 study, sponsored by University of Minnesota.
- Completed
- Registry status
- Phase 1
- Development phase
- 17
- Enrollment target
NCT01884064 is a Phase 1 study that has completed, run by University of Minnesota. The registered enrollment target is 17 participants.
The verdict
NCT01884064, a Phase 1 study, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 17 participants
- Enrollment target
Study Summary
This study investigated the short term effects of repeated administrations of repetitive-transcranial magnetic stimulation (rTMS) on clinical changes and investigate neurophysiologic responses to rTMS of the activated motor system in patients with FHD.
Interventions
- DEVICE Sham rTMS
- DEVICE rTMS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2008-07 |
| Est. Completion | 2010-07 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01884064
The ClinicalTrials.gov registry entry for NCT01884064 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sham rTMS is the first listed.
NCT01884064 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01884064 about?
NCT01884064 is a clinical study titled "Repetitive Transcranial Magnetic Stimulation for the Treatment of Focal Hand Dystonia". This study investigated the short term effects of repeated administrations of repetitive-transcranial magnetic stimulation (rTMS) on clinical changes and investigate neurophysiologic responses to rTMS of the activated motor system in patients with FHD.
What is the current status of trial NCT01884064?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 17 participants. The study started on 2008-07. Estimated completion is 2010-07.
What interventions are being tested in trial NCT01884064?
The interventions under investigation include: Sham rTMS (DEVICE), rTMS (DEVICE).
Who is sponsoring clinical trial NCT01884064?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.